These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 35504258)

  • 1. ANLN Serves as an Oncogene in Bladder Urothelial Carcinoma via Activating JNK Signaling Pathway.
    Chen S; Gao Y; Chen F; Wang TB
    Urol Int; 2023; 107(3):310-320. PubMed ID: 35504258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptome sequencing identifies ANLN as a promising prognostic biomarker in bladder urothelial carcinoma.
    Zeng S; Yu X; Ma C; Song R; Zhang Z; Zi X; Chen X; Wang Y; Yu Y; Zhao J; Wei R; Sun Y; Xu C
    Sci Rep; 2017 Jun; 7(1):3151. PubMed ID: 28600503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Holliday Junction-Recognition Protein-Mediated C-Jun N-Terminal Kinase/ Signal Transducer and Activator of Transcription 3 Signaling Pathway on Cell Proliferation, Cell Cycle and Cell Apoptosis in Bladder Urothelial Carcinoma.
    Gao S; Zhou XQ; Wu Q; Chen XD; Li P; Qin YM
    Tohoku J Exp Med; 2023 Feb; 259(3):209-219. PubMed ID: 36543245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening
    Yang T; Chi Z; Liu G; Hong X; Cao S; Cheng K; Zhang Y
    Front Genet; 2023; 14():1107625. PubMed ID: 37051591
    [No Abstract]   [Full Text] [Related]  

  • 5. LAGE3 promoted cell proliferation, migration, and invasion and inhibited cell apoptosis of hepatocellular carcinoma by facilitating the JNK and ERK signaling pathway.
    Xing Y; Liu Y; Qi Z; Liu Z; Wang X; Zhang H
    Cell Mol Biol Lett; 2021 Nov; 26(1):49. PubMed ID: 34837962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KLK6 Functions as an Oncogene and Unfavorable Prognostic Factor in Bladder Urothelial Carcinoma.
    Zhao K; Gao M; Lin M
    Dis Markers; 2022; 2022():3373851. PubMed ID: 36193495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TEAD4 functions as a prognostic biomarker and triggers EMT via PI3K/AKT pathway in bladder cancer.
    Chi M; Liu J; Mei C; Shi Y; Liu N; Jiang X; Liu C; Xue N; Hong H; Xie J; Sun X; Yin B; Meng X; Wang B
    J Exp Clin Cancer Res; 2022 May; 41(1):175. PubMed ID: 35581606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA TMPO-AS1 promotes proliferation and migration in bladder cancer.
    He YC; Bi YG; Jiang L
    Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):8740-8746. PubMed ID: 32964962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Highly Expressed LINC00958 Modulates the Growth and Epithelial-Mesenchymal Transition of Bladder Cancer Cells Through
    Xiao Y; He L; Dong Y; Huang Y; Ma L; Li W
    Cancer Biother Radiopharm; 2023 Aug; 38(6):405-414. PubMed ID: 35766943
    [No Abstract]   [Full Text] [Related]  

  • 10. Prognostic value of TOP2A in bladder urothelial carcinoma and potential molecular mechanisms.
    Zeng S; Liu A; Dai L; Yu X; Zhang Z; Xiong Q; Yang J; Liu F; Xu J; Xue Y; Sun Y; Xu C
    BMC Cancer; 2019 Jun; 19(1):604. PubMed ID: 31216997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Actin-binding protein Anillin promotes the progression of gastric cancer in vitro and in mice.
    Jia H; Yu F; Li B; Gao Z
    J Clin Lab Anal; 2021 Feb; 35(2):e23635. PubMed ID: 33089886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The oncogenic role of TFAP2A in bladder urothelial carcinoma via a novel long noncoding RNA TPRG1-AS1/DNMT3A/CRTAC1 axis.
    He J; Dong C; Zhang H; Jiang Y; Liu T; Man X
    Cell Signal; 2023 Feb; 102():110527. PubMed ID: 36410635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TUBA1C is a potential new prognostic biomarker and promotes bladder urothelial carcinoma progression by regulating the cell cycle.
    Jiang Y; Zhu C; Huang H; Huang G; Fu B; Xi X
    BMC Cancer; 2023 Aug; 23(1):716. PubMed ID: 37528357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of tryptophan metabolism- and immune-related genes signature and prediction of immune infiltration landscape in bladder urothelial carcinoma.
    Zhou G; Qin G; Zhang Z; Zhao H; Xue L
    Front Immunol; 2023; 14():1283792. PubMed ID: 37954600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-628-5p is a Potential Novel Prognosis Biomarker, Associated with Immune Infiltration in Bladder Urothelial Carcinoma.
    Huang H; Xu Q; Zhang Y; Zhou Y; Ma K; Luo Y
    Curr Pharm Des; 2023; 29(31):2477-2488. PubMed ID: 37916623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. KLHDC7B as a novel diagnostic biomarker in urine exosomal mRNA promotes bladder urothelial carcinoma cell proliferation and migration, inhibits apoptosis.
    Hou J; Huang H; Xie J; Yu W; Hao H; Li H
    Mol Carcinog; 2024 Feb; 63(2):286-300. PubMed ID: 37888201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EGFR activity addiction facilitates anti-ERBB based combination treatment of squamous bladder cancer.
    Rose M; Maurer A; Wirtz J; Bleilevens A; Waldmann T; Wenz M; Eyll M; Geelvink M; Gereitzig M; Rüchel N; Denecke B; Eltze E; Herrmann E; Toma M; Horst D; Grimm T; Denzinger S; Ecke T; Vögeli TA; Knuechel R; Maurer J; Gaisa NT
    Oncogene; 2020 Oct; 39(44):6856-6870. PubMed ID: 32978523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Immune-Related Subtypes and Construction of a Novel Prognostic Model for Bladder Urothelial Cancer.
    Zhang J; Huang C; Yang R; Wang X; Fang B; Mi J; Yuan H; Mo Z; Sun Y
    Biomolecules; 2022 Nov; 12(11):. PubMed ID: 36421685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Prognostic Hub Gene POLE2 Promotes BLCA Cell Growth via the PI3K/AKT Signaling Pathway.
    Jiang D; Zhang H; Yin B; He M; Lu X; He C
    Comb Chem High Throughput Screen; 2024; 27(13):1984-1998. PubMed ID: 38963027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long non-coding RNA ZEB1-AS1 regulates miR-200b/FSCN1 signaling and enhances migration and invasion induced by TGF-β1 in bladder cancer cells.
    Gao R; Zhang N; Yang J; Zhu Y; Zhang Z; Wang J; Xu X; Li Z; Liu X; Li Z; Li J; Kong C; Bi J
    J Exp Clin Cancer Res; 2019 Mar; 38(1):111. PubMed ID: 30823924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.